Abstract:RIG-I-like receptors (RLRs)-mitochondrial antiviral signaling protein (MAVS) are crucial for type I interferon (IFN) signaling pathway and innate immune responses triggered by RNA viruses. However, the regulatory molecular mechanisms underlying RNA virus-activated type I IFN signaling pathway remain incompletely understood. Here, we found that protein arginine methyltransferase 7 (PRMT7) serves as a negative regulator of the type I IFN signaling pathway by interacting with MAVS and catalyzing monomethylation of arginine 232 (R232me1) in MAVS. RNA virus infection leads to the downregulation and dissociation of PRMT7 from MAVS as well as the decrease of R232me1 methylation, enhancing MAVS/RIG-I interaction, MAVS aggregation, type I IFN signaling activation, and antiviral immune responses. Knock-in mice with MAVS R232 substituted with lysine ( Mavs R232K -KI) are more resistant to Vesicular Stomatitis Virus infection due to enhanced antiviral immune responses. PiPRMT7-MAVS, a short peptide inhibitor designed to interrupt the interaction between PRMT7 and MAVS, inhibits R232me1 methylation, thereby enhancing MAVS/RIG-I interaction, promoting MAVS aggregation, activating type I IFN signaling, and bolstering antiviral immune responses to suppress RNA virus replication. Moreover, the clinical relevance of PRMT7 is highlighted that it is significantly downregulated in RNA virus-infected clinical samples, such as blood samples from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Ebola virus, as well as H1N1-infected bronchial epithelial cells. Our findings uncovered that PRMT7-mediated arginine methylation plays critical roles in regulating MAVS-mediated antiviral innate immune responses, and targeting arginine methylation might represent a therapeutic avenue for treating RNA viral infection.

Protein Arginine Methylation in Viral Infection and Antiviral Immunity

Arginine Methylation Regulates SARS-CoV-2 Nucleocapsid Protein Function and Viral Replication

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy

The regulation, functions and clinical relevance of arginine methylation

Critical Roles of Protein Arginine Methylation in the Central Nervous System

Protein arginine methylation: from enigmatic functions to therapeutic targeting

Protein arginine methylation of non-histone proteins and its role in diseases.

Dysregulation of arginine methylation in tumorigenesis

Arginine monomethylation by PRMT7 controls MAVS-mediated antiviral innate immunity

The role of protein arginine N-methyltransferases in inflammation

Protein Arginine Methyltransferases in Cardiovascular and Neuronal Function

Protein Arginine Methyltransferases (PRMTs): Orchestrators of Cancer Pathogenesis, Immunotherapy Dynamics, and Drug Resistance

Targeting PRMT7-mediated Monomethylation of MAVS Enhances Antiviral Innate Immune Responses and Inhibits RNA Virus Replication

PRMT1 in human neoplasm: cancer biology and potential therapeutic target

Protein Acetylation Going Viral: Implications in Antiviral Immunity and Viral Infection

The protein arginine methyltransferase PRMT1 promotes TBK1 activation through asymmetric arginine methylation

Chemical probes and methods for the study of protein arginine methylation

Protein Arginine Methyltransferase 5 Mediates Arginine Symmetric Dimethylation of Influenza A Virus PB2 and Supports Viral Replication

Post-translational regulation of antiviral innate signaling

The Role of PRMT1 in Cellular Regulation and Disease: Insights into Biochemical Functions and Emerging Inhibitors for Cancer Therapy

The protein arginine methyltransferase PRMT9 attenuates MAVS activation through arginine methylation